A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity.
Conference Paper
Full Text
Duke Authors
- Abbruzzese, James
- Blazer III, Dan German
- Blobe, Gerard Conrad
- Czito, Brian Gary
- Niedzwiecki, Donna
- Palta, Manisha
- Uronis, Hope Elizabeth
Cited Authors
- Palta, M; Czito, BG; Duffy, E; Malicki, M; Niedzwiecki, D; Abbruzzese, JL; Uronis, HE; Blobe, GC; Blazer, DG; Willett, C
Published Date
- May 20, 2018
Published In
Volume / Issue
- 36 / 15_suppl
Start / End Page
- 4121 - 4121
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2018.36.15_suppl.4121